CD8A and non-small cell lung carcinoma: Zhang et al. (39) reported high PD-1 expression on dysfunctional CD8+ T cells from PBMC and tissue of human non-small cell lung cancer, and blocking PD-1/PD-L1 pathway using PD-L1-specific antibody partially restored proliferation and cytokine production in these cells.